Literature DB >> 18054899

Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity.

Nicolas C Royo1, Luk H Vandenberghe, Jing-Yuan Ma, Alisse Hauspurg, Liya Yu, Margaret Maronski, Julie Johnston, Marc A Dichter, James M Wilson, Deborah J Watson.   

Abstract

Most current methods of gene delivery for primary cultured hippocampal neurons are limited by toxicity, transient expression, the use of immature neurons and/or low efficiency. We performed a direct comparison of seven serotypes of adeno-associated virus (AAV) vectors for genetic manipulation of primary cultured neurons in vitro. Serotypes 1, 2, 7, 8 and 9 mediated highly efficient, nontoxic, stable long-term gene expression in cultured cortical and hippocampal neurons aged 0-4 weeks in vitro; serotypes 5 and 6 were associated with toxicity at high doses. AAV1 transduced over 90% of all cells with approximately 80% of the transduced cells being neurons. The method was readily adapted to a high-throughput format to demonstrate neurotrophin-mediated neuroprotection from glutamate toxicity in cultured neurons at 2 weeks in vitro. These vectors should prove highly useful for efficient overexpression or downregulation of genes in primary neuronal cultures at any developmental stage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054899      PMCID: PMC2367141          DOI: 10.1016/j.brainres.2007.11.015

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Recombinant adeno-associated virus serotype 2 effectively transduces primary rat brain astrocytes and microglia.

Authors:  Yan Gong; Shuzhen Chen; Christopher F Sonntag; Colin Sumners; Ronald L Klein; Michael A King; Jeffrey A Hughes; Edwin M Meyer
Journal:  Brain Res Brain Res Protoc       Date:  2004-11

Review 2.  New recombinant serotypes of AAV vectors.

Authors:  Guangping Gao; Luk H Vandenberghe; James M Wilson
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

3.  Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.

Authors:  M L D Broekman; L A Comer; B T Hyman; M Sena-Esteves
Journal:  Neuroscience       Date:  2006-01-18       Impact factor: 3.590

4.  Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

Authors:  Yuji Kashiwakura; Kenji Tamayose; Kazuhisa Iwabuchi; Yukihiko Hirai; Takashi Shimada; Kunio Matsumoto; Toshikazu Nakamura; Masami Watanabe; Kazuo Oshimi; Hiroyuki Daida
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Recombinant adeno-associated virus for muscle directed gene therapy.

Authors:  K J Fisher; K Jooss; J Alston; Y Yang; S E Haecker; K High; R Pathak; S E Raper; J M Wilson
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

6.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.

Authors:  C Y Wang; H Y Guo; T M Lim; Y K Ng; H P Neo; P Y K Hwang; W-C Yee; S Wang
Journal:  J Gene Med       Date:  2005-07       Impact factor: 4.565

8.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

Authors:  K Qing; C Mah; J Hansen; S Zhou; V Dwarki; A Srivastava
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

9.  AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.

Authors:  C Summerford; J S Bartlett; R J Samulski
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

Review 10.  Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.

Authors:  Z Shevtsova; J M I Malik; U Michel; M Bähr; S Kügler
Journal:  Exp Physiol       Date:  2004-11-12       Impact factor: 2.969

View more
  43 in total

1.  Astrocytic responses to DNA delivery using nucleofection.

Authors:  H Muyderman; W P Yew; B Homkajorn; N R Sims
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

Review 2.  Transfection techniques for neuronal cells.

Authors:  Daniela Karra; Ralf Dahm
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Emerging role of viral vectors for circuit-specific gene interrogation and manipulation in rodent brain.

Authors:  Erika Sarno; Alfred J Robison
Journal:  Pharmacol Biochem Behav       Date:  2018-04-27       Impact factor: 3.533

4.  Visualization of cortical, subcortical and deep brain neural circuit dynamics during naturalistic mammalian behavior with head-mounted microscopes and chronically implanted lenses.

Authors:  Shanna L Resendez; Josh H Jennings; Randall L Ung; Vijay Mohan K Namboodiri; Zhe Charles Zhou; James M Otis; Hiroshi Nomura; Jenna A McHenry; Oksana Kosyk; Garret D Stuber
Journal:  Nat Protoc       Date:  2016-02-25       Impact factor: 13.491

5.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

6.  Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Joshua S Selfe; John Hamin Lee; Maurits van den Berg; Alexandru Calin; Neela K Codadu; Rebecca Wright; Sarah E Newey; R Ryley Parrish; Arieh A Katz; Jo M Wilmshurst; Colin J Akerman; Andrew J Trevelyan; Joseph V Raimondo
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

7.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

8.  Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model.

Authors:  Jinghong Kou; HongDuck Kim; Abhinandan Pattanayak; Min Song; Jeong-Eun Lim; Hiroaki Taguchi; Sudhir Paul; John R Cirrito; Selvarangan Ponnazhagan; Ken-ichiro Fukuchi
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

Authors:  Michael J Castle; Heikki T Turunen; Luk H Vandenberghe; John H Wolfe
Journal:  Methods Mol Biol       Date:  2016

10.  Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

Authors:  L H Vandenberghe; E Breous; H-J Nam; G Gao; R Xiao; A Sandhu; J Johnston; Z Debyser; M Agbandje-McKenna; J M Wilson
Journal:  Gene Ther       Date:  2009-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.